A More Personalized Approach To PSA Screening In 2017 - Alexandria Bachert, MPH
A More Personalized Approach To PSA Screening In 2017 - Alexandria Bachert, MPH
In April the U.S. Preventative Services Task Force released an updated recommendation supporting individualized decision-making for PSA-based prostate cancer screening among men ages 55 to 69 years old. The release stated that men should have the opportunity to weigh the potential benefits and harms of screening and make a decision based on their own values and preferences. William K. Oh, MD, professor of medicine, hematology, medical oncology, and urology, and deputy director of the Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai, shared a cautious perspective: "When the previous recommendation was announced that patients should not be screened at all, I do think it decreased screening rates," he explained. "I think this change will slowly increase screening again, but I don't think it will happen quickly. Unfortunately, I think these rapid back-and-forth changes have the effect of causing clinicians to become confused and potentially not respond to guidelines."
- William Oh, MD, Professor, Medicine, Hematology, Medical Oncology, Urology, Deputy Director, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai